BRIEF published on 07/17/2025 at 15:50, 7 months 18 days ago The Vanguard Group Discloses Interests in Unite Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Unite Group Plc
BRIEF published on 07/17/2025 at 15:50, 7 months 18 days ago Le groupe Vanguard révèle ses participations dans Unite Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Valeurs Mobilières Groupe Unite Plc
PRESS RELEASE published on 07/17/2025 at 15:49, 7 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. discloses 5.64% stake in Primary Health Properties plc. Further discloses dealings with 12.5p ordinary shares The Vanguard Group Dealings Stake 12.5p Ordinary Shares Primary Health Properties Plc
BRIEF published on 07/17/2025 at 15:49, 7 months 18 days ago The Vanguard Group Discloses Significant Stake in Spirent Communications Form 8.3 Takeover Code Vanguard Group Stake Disclosure Spirent Communications
BRIEF published on 07/17/2025 at 15:49, 7 months 18 days ago Le groupe Vanguard révèle une participation significative dans Spirent Communications Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Spirent Communications Divulgation Des Enjeux
PRESS RELEASE published on 07/17/2025 at 15:49, 7 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses public position on Assura plc with 5.70% ownership as of 16 July 2025. Primary Health Properties plc also involved in disclosures Vanguard Group Ownership Disclosure Public Position Assura Plc Primary Health Properties
PRESS RELEASE published on 07/17/2025 at 15:48, 7 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses owning 1.42% in Alphawave IP Group plc as of 16 July 2025. Also making disclosures related to Qualcomm Incorporated Disclosure Vanguard Group Inc. Alphawave IP Group Plc Quantum Incorporated
PRESS RELEASE published on 07/17/2025 at 15:47, 7 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc The Vanguard Group, Inc. discloses 3.89% ownership of Deliveroo plc securities as of 16 July 2025. Details in Form 8.3 filing Securities Form 8.3 The Vanguard Group Deliveroo PLC Ownership
PRESS RELEASE published on 07/17/2025 at 15:47, 7 months 18 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. files Form 8.3 disclosing a 5.51% stake in Dowlais Group plc, with 72,526,196 ordinary shares owned Shares Form 8.3 Disclosure Vanguard Group Dowlais Group Plc
BRIEF published on 07/17/2025 at 15:47, 7 months 18 days ago Vanguard Group Discloses Position in Spectris plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Spectris Plc
Published on 03/05/2026 at 14:00, 1 hour 5 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 1 hour 5 minutes ago GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 1 hour 5 minutes ago Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 1 hour 25 minutes ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 1 hour 35 minutes ago Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 14:35, 30 minutes ago Lio Raises $30M Series A to Bring Agentic AI to Enterprise Procurement
Published on 03/05/2026 at 14:25, 40 minutes ago Beef.com Launches Infrastructure Blueprint to Build the Digital Backbone of a Rancher-First Food Economy
Published on 03/05/2026 at 14:00, 1 hour 5 minutes ago Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD™ 2026 Conference
Published on 03/05/2026 at 13:43, 1 hour 22 minutes ago Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
